SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    E Judd, D A Calhoun, Apparent and true resistant hypertension: definition, prevalence and outcomes, Journal of Human Hypertension, 2014, 28, 8, 463

    CrossRef

  2. 2
    Pantelis A. Sarafidis, Panagiotis I. Georgianos, Pantelis E. Zebekakis, Comparative Epidemiology of Resistant Hypertension in Chronic Kidney Disease and the General Hypertensive Population, Seminars in Nephrology, 2014, 34, 5, 483

    CrossRef

  3. 3
    Hélder Dores, Manuel de Sousa Almeida, Pedro de Araújo Gonçalves, Patrícia Branco, Augusta Gaspar, Henrique Sousa, Angela Canha Gomes, Maria João Andrade, Maria Salomé Carvalho, Rui Campante Teles, Luís Raposo, Henrique Mesquita Gabriel, Francisco Pereira Machado, Miguel Mendes, Desnervação renal em doentes com hipertensão arterial resistente: resultados aos seis meses de seguimento, Revista Portuguesa de Cardiologia, 2014, 33, 4, 197

    CrossRef

  4. 4
    Kristian B. Buhl, Christina S. Oxlund, Ulla G. Friis, Per Svenningsen, Claus Bistrup, Ib A. Jacobsen, Boye L. Jensen, Plasmin in urine from patients with type 2 diabetes and treatment-resistant hypertension activates ENaC in vitro, Journal of Hypertension, 2014, 32, 8, 1672

    CrossRef

  5. 5
    Jorge Polonia, Luis Martins, Fernando Pinto, Jose Nazare, Prevalence, awareness, treatment and control of hypertension and salt intake in Portugal, Journal of Hypertension, 2014, 32, 6, 1211

    CrossRef

  6. 6
    Hélder Dores, Manuel de Sousa Almeida, Pedro de Araújo Gonçalves, Patrícia Branco, Augusta Gaspar, Henrique Sousa, Angela Canha Gomes, Maria João Andrade, Maria Salomé Carvalho, Rui Campante Teles, Luís Raposo, Henrique Mesquita Gabriel, Francisco Pereira Machado, Miguel Mendes, Renal denervation in patients with resistant hypertension: Six-month results, Revista Portuguesa de Cardiologia (English Edition), 2014, 33, 4, 197

    CrossRef

  7. 7
    Joshua Vega, John D. Bisognano, The Prevalence, Incidence, Prognosis, and Associated Conditions of Resistant Hypertension, Seminars in Nephrology, 2014, 34, 3, 247

    CrossRef

  8. 8
    Athanase D Protogerou, Demosthenis B Panagiotakos, Evangelia Zampeli, Antonis A Argyris, Katerina Arida, Giorgos D Konstantonis, Christos Pitsavos, George D Kitas, Petros P Sfikakis, Arterial hypertension assessed “out-of-office” in a contemporary cohort of rheumatoid arthritis patients free of cardiovascular disease is characterized by high prevalence, low awareness, poor control and increased vascular damage-associated “white coat” phenomenon, Arthritis Research & Therapy, 2013, 15, 5, R142

    CrossRef

  9. 9
    John J. Sim, Simran K. Bhandari, Jiaxiao Shi, In Lu A. Liu, David A. Calhoun, Elizabeth A. McGlynn, Kamyar Kalantar-Zadeh, Steven J. Jacobsen, Characteristics of Resistant Hypertension in a Large, Ethnically Diverse Hypertension Population of an Integrated Health System, Mayo Clinic Proceedings, 2013, 88, 10, 1099

    CrossRef

  10. You have free access to this content10
    Michael A. Weber, Exploring Issues in Difficult-to-Treat Hypertension, The Journal of Clinical Hypertension, 2013, 15, 12
  11. 11
    Anna Solini, Luis M. Ruilope, How can resistant hypertension be identified and prevented?, Nature Reviews Cardiology, 2013, 10, 5, 293

    CrossRef

  12. 12
    S. Häfner, J. Baumert, R.T. Emeny, M.E. Lacruz, M. Bidlingmaier, M. Reincke, K.H. Ladwig, Hypertension and depressed symptomatology: A cluster related to the activation of the renin–angiotensin–aldosterone system (RAAS). Findings from population based KORA F4 study, Psychoneuroendocrinology, 2013, 38, 10, 2065

    CrossRef

  13. 13
    WA Nuwan Kumara, Thisara Perera, Mekhala Dissanayake, Priyanga Ranasinghe, Godwin R Constantine, Prevalence and risk factors for resistant hypertension among hypertensive patients from a developing country, BMC Research Notes, 2013, 6, 1, 373

    CrossRef

  14. 14
    Daichi Shimbo, Emily B. Levitan, John N. Booth, David A. Calhoun, Suzanne E. Judd, Daniel T. Lackland, Monika M. Safford, Suzanne Oparil, Paul Muntner, The contributions of unhealthy lifestyle factors to apparent resistant hypertension, Journal of Hypertension, 2013, 31, 2, 370

    CrossRef

  15. 15
    Débora R. Ramos, Nauilo L. Costa, Karen L.L. Jang, Ivone B. Oliveira, Alexandre A. da Silva, Joel C. Heimann, Luzia N.S. Furukawa, Maternal high-sodium intake alters the responsiveness of the renin–angiotensin system in adult offspring, Life Sciences, 2012, 90, 19-20, 785

    CrossRef

  16. 16
    Pantelis A. Sarafidis, Claire C. Sharpe, Eleri Wood, Rochelle Blacklock, Adam Rumjon, Aziza Al-Yassin, Rachel Ariyanayagam, Shanique Simmonds, Jessica Fletcher-Rogers, Katie Vinen, Prevalence, Patterns of Treatment, and Control of Hypertension in Predialysis Patients with Chronic Kidney Disease, Nephron Clinical Practice, 2012, 120, 3, 147

    CrossRef

  17. 17
    Pantelis A. Sarafidis, Panagiotis Georgianos, George L. Bakris, Resistant hypertension—its identification and epidemiology, Nature Reviews Nephrology, 2012, 9, 1, 51

    CrossRef

  18. 18
    Dustin R. Roberie, William J. Elliott, What is the prevalence of resistant hypertension in the United States?, Current Opinion in Cardiology, 2012, 27, 4, 386

    CrossRef